Immetric

Immetric is a precision immunology company that leverages high-dimensional transcriptomic data and machine learning to quantify the human immune system. The company's platform is built on proprietary multicohort analysis techniques that identify conserved immune signatures across a wide range of conditions, including autoimmune diseases, infections, and oncology. By providing a standardized metric for immune health, Immetric enables pharmaceutical companies to improve target discovery, optimize patient stratification in clinical trials, and monitor treatment responses more accurately. Headquartered in Menlo Park, the company aims to transition immunology from a descriptive science to a quantitative, actionable discipline. Immetric is backed by leading venture capital firms such as Andreessen Horowitz and Casdin Capital.